{"id":"W3138793908","doi":"10.3390/jcm10061242","title":"Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease","year":2021,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Pfizer; Amgen","keywords":"Vedolizumab; Medicine; Tofacitinib; Ustekinumab; Therapeutic drug monitoring; Inflammatory bowel disease; Drug; Fingolimod; Tumor necrosis factor alpha; Crohn's disease; Pharmacokinetics; Adalimumab; Intensive care medicine; Pharmacology; Disease; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048875,0.0007095744,0.001530715,0.002351785,0.000208013,0.001084156,0.0009668643,0.001325346,0.003688883],"category_scores_gemma":[0.00131115,0.000308948,0.0009329218,0.002119422,0.0003364474,0.001385708,0.0006432959,0.00226575,0.001967848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00059653,"about_ca_system_score_gemma":0.0009927333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007994125,"about_ca_topic_score_gemma":0.001467909,"domain_scores_codex":[0.9996638,0.00008029505,0.00006201041,0.00004294169,0.0001268821,0.00002400703],"domain_scores_gemma":[0.999305,0.0003793235,0.0001087101,0.00001336319,0.0001468617,0.00004660496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000115864,0.00008536242,0.0001770815,0.01954796,0.0001613456,0.0002720935,0.00005433453,0.0003183881,0.00120273,0.002363592,0.04496825,0.9307329],"study_design_scores_gemma":[0.00003867823,0.0001348624,0.0007239701,0.005352129,0.0002757936,0.001473289,0.0000295334,0.0001184778,0.0003651557,0.0008802976,0.99059,0.00001791927],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001054331,0.9983388,0.0001490711,0.0003825211,0.0002694183,0.000006299695,0.0000325287,0.00001015428,0.000705813],"genre_scores_gemma":[0.0005122614,0.9980487,0.0002970231,0.0003587158,0.0002784591,0.00001000138,0.00005936861,0.000002276031,0.0004333039],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003688883,"threshold_uncertainty_score":0.01234049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04688484297190361,"score_gpt":0.3941969818085239,"score_spread":0.3473121388366203,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}